AMRZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amrize AG (AMRZ) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has strong analyst support with increasing price targets and positive sentiment, the technical indicators and financial performance do not currently signal a compelling entry point. The lack of significant recent news or catalysts, combined with neutral hedge fund and insider trading trends, suggests holding off on immediate action.
The MACD is negatively contracting at -0.96, RSI is neutral at 21.648, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 53.979), with resistance levels at R1: 59.342 and R2: 60.999. Overall, the technical indicators suggest a lack of strong momentum for a buy.
Analysts have consistently raised price targets, with the most recent targets ranging from $66 to $76, citing improved growth prospects, shareholder yield, and above-consensus guidance. The company's Q4 2025 results showed moderate growth in profitability and revenue guidance for 2026.
The company's Q4 2025 revenue dropped by -0.35% YoY, and gross margin decreased by -1.83% YoY. Technical indicators do not show strong momentum, and there is no significant hedge fund or insider trading activity to support a buy decision.
In Q4 2025, revenue dropped slightly (-0.35% YoY), but net income increased by 2.41% YoY, and EPS grew by 1.89% YoY. Gross margin decreased to 26.77%, down -1.83% YoY, indicating some cost pressures.
Analysts are overwhelmingly positive, with multiple firms raising price targets and maintaining Buy or Overweight ratings. The most recent price targets range from $66 to $76, reflecting optimism about the company's growth prospects and shareholder returns.
